A management of patients suffering from Alzheimer’s disease at the heart of the Group’s concerns
Press release, September 21, 2020
21 September 20202020 half-year results
22 September 2020
With an estimated of 100 million new patients diagnosed worldwide by 2050, the importance of treating Alzheimer’s disease remains a priority for ORPEA Group.
